Dry Needling, Manual Therapy and Exercise for Neck Pain Management
Efficacy of Adding Dry Needling to a Manual Therapy and Therapeutic Exercise Interventions for Managing Neck Pain Populations: A Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
Since neck pain is the fourth highest disabling condition (with an estimated point prevalence of 20%, lifetime prevalence up to 70% and high recurrence rates), dry needling targeting myofascial trigger points in neck muscles has been proposed as an effective treatment for reducing pain and disability in patients with chronic neck pain. A recent meta-analysis reported whether dry needling could be recommended for this population. Low to moderate evidence suggests that dry needling can be effective at the short-term, but its effects on pressure pain sensitivity or cervical range of motion are limited.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedFirst Posted
Study publicly available on registry
November 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2025
CompletedJuly 1, 2025
June 1, 2025
2.4 years
October 28, 2022
June 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Visual Analogue Scale
A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)
Baseline
Visual Analogue Scale
A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)
One month follow-up
Visual Analogue Scale
A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)
Three months follow-up
Visual Analogue Scale
A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)
Six months follow-up
Visual Analogue Scale
A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)
Twelve months follow-up
Secondary Outcomes (20)
Pittsburg Sleeping Quality Index
Baseline
Pittsburg Sleeping Quality Index
One month follow-up
Pittsburg Sleeping Quality Index
Three months follow-up
Pittsburg Sleeping Quality Index
Six months follow-up
Pittsburg Sleeping Quality Index
Twelve months follow-up
- +15 more secondary outcomes
Study Arms (2)
Dry Needling Group
EXPERIMENTALThis group will receive dry needling, manual therapy (consisting of a manual compression over myofascial trigger points located at the upper trapezius muscle, scalene muscles and cervical multifidus) and therapeutic exercise interventions
Sham Dry Needling Group
ACTIVE COMPARATORThis group will receive manual therapy (consisting of a manual compression over myofascial trigger points located at the upper trapezius muscle, scalene muscles and cervical multifidus), therapeutic exercise interventions and a previously described sham dry needling intervention.
Interventions
Dry needling consists of a skilled intervention which uses a thin filiform needle (as those used in acupuncture) to penetrate the skin and stimulate underlying myofascial trigger points (defined as "a hyperirritable spot in skeletal muscle that is associated with a hypersensitive palpable nodule in a taut band which is painful on manual compression and can give rise to characteristic referred pain, referred tenderness, motor dysfunction and autonomic phenomena.") This intervention will be performed targeting the upper trapezius and cervical multifidus muscles
Patients will include a supervised therapeutic exercise program in their daily life, based on strengthening exercises for neck muscles.
Patients will receive a manual compression (30 seconds) over myofascial trigger points located at the upper trapezius muscle, scalene muscles and cervical multifidus muscle.
For the sham DN intervention, a similar approach will be used, but the skin will be not pierced since the material used will be a telescopic Park's sham device. The guide tube will be pressed against the skin mark and the sham needle will be allowed to drop. The handle will be tapped briskly, but the (blunted) needle tip will not not break the skin.
Eligibility Criteria
You may qualify if:
- To be between 18 and 65 years old
- To have been experiencing unilateral neck pain for at least 3 months
- To have a Neck Disability Index (NDI) score \>8
- To have a Visual Analogue Scale (VAS) score \>3
- To have at least one active MTrP located in the upper trapezius or cervical multifidus muscles
You may not qualify if:
- History of whiplash injury
- Previous cervical surgery
- Cervical radiculopathy or myelopathy
- Diagnosis of fibromyalgia
- Additional analgesic treatments during the study (e.g. physiotherapy or drugs)
- Psychiatric disorders
- Any contraindication to the interventions proposed (e.g. fear of needles or anticoagulants)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Camilo Jose Cela Universitylead
- Universidad Rey Juan Carloscollaborator
Study Sites (1)
Juan Antonio Valera-Calero
Alcorcón, Madrid, 28922, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juan Antonio Valera Calero, PhD
Camilo José Cela University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice-dean of research
Study Record Dates
First Submitted
October 28, 2022
First Posted
November 7, 2022
Study Start
November 1, 2022
Primary Completion
March 28, 2025
Study Completion
March 30, 2025
Last Updated
July 1, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share